WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Various events introduced for students at museums in Xi'anRevenue of China's stateChina, Singapore to implement 30Wild giant panda population in China increases to nearly 1,900Village in China's Henan transformed by cultural industriesChina contributes over 50% growth to global renewable energy capacity in 2023China holds conference on internet civilizationVillage in China's Henan transformed by cultural industriesVisa exemption agreement will further enhance SinoChina holds conference on internet civilization
2.9843s , 6498.125 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Culture Crossroad news portal